• Can be expanded as adherent or neurosphere suspension cell cultures
  • During expansion more than 75% of NSCs retain undifferentiated phenotype
  • Supports differentiation into neurons, astrocytes and oligodendrocytes
  • Superior cell viability to competitors—greater than 70% post-thaw viability.
  • Cryopreserved at the end of first passage—can be further expanded for at least 2 additional passages.
  • High cell purity- More than 90% of the cells remain positive for astrocyte specific marker glial fibrillary acid protein (GFAP).
  • Upon proliferation in GPC recovery media (StemPro® NSC SFM and PDGF-AA), more than 80% of GPCs maintain their undifferentiated phenotype
  • Supports differentiation into oligodendrocytes and astrocytes
  • More than 2-fold increase in cells upon recovery
  • Minimize assay variability with ischemic tolerant NSCs manufactured using GMP manufacturing standards
  • Improve functionality studies with immature, high potency NSCs
  • Complete experiments requiring one large lot of NSCs
  • Minimize your chance of assay failure by using tested cells, reagents, and protocols


For Research Use Only. Not for use in diagnostic procedures.